Please Wait...

BioClinica Compass™ Wins Technology Innovation Award

– Risk-Based Monitoring Solution Recognized at SCDM Annual Conference –

September 30, 2014

BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced that its Compass technology, a risk-based monitoring solution that improves overall quality in clinical trials, has won the inaugural Society for Clinical Data Management (SCDM) NextGen Technology Innovation (TIA) Award, presented as part of SCDM's 2014 annual conference.

BioClinica's entry utilizes "Intelligent Monitoring" to transform the way clinical trials are managed.  Compass focuses on meaningful data, critical to the success of a trial, and makes it easy to view the overall performance of trial sites. Compass leverages intelligent monitoring to track trial performance and identify performance issues across sites and ensure the most efficient and effective use of resources.


Courtney McBean presents Compass to the SCDM Audience as part of the NextGen Awards competition.

The SCDM Award recognizes breakthrough innovations which use novel technologies or processes and provide real-life application for use in clinical trials. Compass, along with entrees from Maxisit and PHT, was chosen as a finalist from a broad field of entries. Courtney McBean, BioClinica's Vice President of Clinical Innovation, presented Compass to an enthusiastic SCDM audience as part of the competition.

"On behalf of SCDM, I would like to congratulate BioClinica on winning our inaugural NextGen Technology Innovation Award and thank all of our participating companies for their entries," said Derek Perrin, SCDM Vice-Chair. "Compass is exactly the kind of technology solution we want to highlight with this award. It is an innovative solution to meeting the newest challenge in clinical trials."

"This award not only recognizes the value Compass brings to clinical research, it also represents the clinical trial community's interest and willingness to embrace a new approach to monitoring," said BioClinica CEO Mark Weinstein. "The FDA has made it clear – we should be focusing our attention on the data that matters most – and Compass is a valuable tool to help trial sponsors accomplish this objective."

Courtney McBean will participate in a Risk-Based Monitoring panel at the upcoming Partnerships in Clinical Trials Europe conference in Barcelona, Spain. She will also be presenting a webinar to the clinical trial industry titled An Intelligent Approach to Risk-Based Monitoring - How People, Process and Tools can Improve Clinical Trial Quality on November 13th.

Other upcoming industry events where BioClinica is participating include:

At each of these conferences, attendees will have an opportunity to converse with knowledgeable BioClinica representatives on latest trends in clinical trials and see live product demonstrations. To request a meeting with BioClinica during any of these events, call our hotline at 1-888-392-7456, email or use our online Contact Us form.

An Intelligent Approach to Risk-Based Monitoring - Register Now!

About Bioclinica

Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serve more than 500 pharmaceutical, biotechnology and device organizations – including the top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia.




Media Contact
Nicole Klatsky
+1 (609) 865-5212

Learn more about Bioclinica at and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica's #ClinicalDataManagement ecosystem of global experts, templates, coding tools and more fills the gap in…
Bioclinica (Yesterday)
With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a…
Bioclinica (3 weeks ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour…
Bioclinica (3 weeks ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff…
Bioclinica (4 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app…
Bioclinica (4 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin…
Bioclinica (5 weeks ago)